BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 23 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $240,000 | +22.4% | 55,241 | 0.0% | 0.01% | +11.1% |
| Q4 2018 | $196,000 | -7.1% | 55,241 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $211,000 | -1.9% | 55,241 | 0.0% | 0.01% | -10.0% |
| Q2 2018 | $215,000 | +74.8% | 55,241 | +41.2% | 0.01% | +100.0% |
| Q1 2018 | $123,000 | -19.6% | 39,115 | 0.0% | 0.01% | -28.6% |
| Q4 2017 | $153,000 | -5.0% | 39,115 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $161,000 | -0.6% | 39,115 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $162,000 | -2.4% | 39,115 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $166,000 | +66.0% | 39,115 | -0.2% | 0.01% | +75.0% |
| Q4 2016 | $100,000 | +6.4% | 39,203 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $94,000 | +70.9% | 39,203 | +72.6% | 0.00% | +100.0% |
| Q2 2016 | $55,000 | -9.8% | 22,715 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $61,000 | +96.8% | 22,715 | +112.0% | 0.00% | +200.0% |
| Q4 2015 | $31,000 | +24.0% | 10,715 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $25,000 | -35.9% | 10,715 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $39,000 | -18.8% | 10,715 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $48,000 | – | 10,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABNER HERRMAN & BROCK LLC | 239,000 | $2,679,000 | 0.48% |
| EAM Investors, LLC | 81,854 | $918,000 | 0.20% |
| CFO4Life Group, LLC | 12,003 | $135,000 | 0.05% |
| Phoenix Holdings Ltd. | 104,782 | $1,112,000 | 0.05% |
| WINTON GROUP Ltd | 118,487 | $1,328,000 | 0.03% |
| Merit Financial Group, LLC | 28,731 | $322,000 | 0.03% |
| HighPoint Advisor Group LLC | 13,533 | $151,000 | 0.03% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 23,000 | $258,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 52,216 | $579,000 | 0.02% |
| IHT Wealth Management, LLC | 13,000 | $146,000 | 0.02% |